UK Penny Stocks To Watch In September 2025

The United Kingdom's stock market has recently faced challenges, with the FTSE 100 index experiencing declines due to weak trade data from China, highlighting ongoing global economic uncertainties. Despite these broader market pressures, penny stocks continue to capture investor interest as they represent opportunities in smaller or newer companies that may offer significant growth potential. While the term "penny stock" might seem outdated, these investments can still provide value when backed by strong financials and a clear growth path.

Advertisement

Top 10 Penny Stocks In The United Kingdom

NameShare PriceMarket CapRewards & Risks
Foresight Group Holdings (LSE:FSG)£4.615£516.68M✅ 4 ⚠️ 0 View Analysis >
Warpaint London (AIM:W7L)£2.20£177.73M✅ 4 ⚠️ 2 View Analysis >
Van Elle Holdings (AIM:VANL)£0.40£43.28M✅ 4 ⚠️ 3 View Analysis >
Polar Capital Holdings (AIM:POLR)£4.515£435.27M✅ 4 ⚠️ 1 View Analysis >
Integrated Diagnostics Holdings (LSE:IDHC)$0.56$325.54M✅ 4 ⚠️ 1 View Analysis >
LSL Property Services (LSE:LSL)£2.79£286.66M✅ 4 ⚠️ 1 View Analysis >
Alumasc Group (AIM:ALU)£3.20£115.07M✅ 4 ⚠️ 1 View Analysis >
Begbies Traynor Group (AIM:BEG)£1.19£189.45M✅ 4 ⚠️ 3 View Analysis >
Croma Security Solutions Group (AIM:CSSG)£0.75£10.33M✅ 3 ⚠️ 3 View Analysis >
Braemar (LSE:BMS)£2.54£77.39M✅ 3 ⚠️ 3 View Analysis >

Click here to see the full list of 297 stocks from our UK Penny Stocks screener.

Here's a peek at a few of the choices from the screener.

Altitude Group (AIM:ALT)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Altitude Group plc offers comprehensive solutions for branded merchandise within the corporate promotional products industry, print vertical markets, and the higher-education sector across North America, the United Kingdom, and Europe, with a market cap of £19.69 million.

Operations: The company generates revenue from North America at $35.83 million and the United Kingdom and Europe at $1.43 million.

Market Cap: £19.69M

Altitude Group plc, with a market cap of £19.69 million, has shown promising financial performance in recent times, reporting sales of US$37.26 million for the year ending March 31, 2025. The company is debt-free and its short-term assets exceed both short-term and long-term liabilities significantly. Despite a low Return on Equity at 7.8%, Altitude's net profit margins have improved to 3.2%. However, leadership changes could pose challenges; Nichole Stella stepped down as CEO in July 2025 amidst executive reshuffles including the appointment of Drew Whibley as CFO effective September 2025.

AIM:ALT Debt to Equity History and Analysis as at Sep 2025
AIM:ALT Debt to Equity History and Analysis as at Sep 2025

Polar Capital Holdings (AIM:POLR)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Polar Capital Holdings plc is a publicly owned investment manager with a market cap of £435.27 million.

Operations: The company generates revenue of £226.11 million from its investment management business.

Market Cap: £435.27M

Polar Capital Holdings plc, with a market cap of £435.27 million, faces challenges as earnings declined by 13.4% over the past year despite revenue growth to £226.11 million. The company is debt-free and its short-term assets exceed liabilities significantly, suggesting financial stability. However, dividends at 10.19% are not well covered by earnings, raising sustainability concerns. Leadership transition is underway with Iain Evans set to replace retiring CEO Gavin Rochussen in September 2025 following an executive search process. Trading below fair value estimates and with high Return on Equity at 26.3%, it remains an intriguing option for investors seeking undervalued stocks.

AIM:POLR Debt to Equity History and Analysis as at Sep 2025
AIM:POLR Debt to Equity History and Analysis as at Sep 2025

MOH Nippon (LSE:MOH)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: MOH Nippon Plc offers real estate crowdfunding services in Japan and has a market cap of £62.65 million.

Operations: The company's revenue is derived from two main segments: Commission Revenue, amounting to ¥1.91 billion, and the Real Estate Business, contributing ¥2.10 billion.

Market Cap: £62.65M

MOH Nippon Plc, with a market cap of £62.65 million, is navigating significant challenges as it reported a substantial revenue decline to ¥4 billion from ¥11.11 billion year-over-year and incurred a net loss of ¥1.47 billion. Despite being debt-free for the past five years and having short-term assets of ¥5.2 billion that comfortably cover both short- and long-term liabilities, the company remains unprofitable with negative returns on equity at -25.83%. Recent changes include appointing MacIntyre Hudson LLP as auditors amid an inexperienced management team averaging 1.1 years in tenure, highlighting operational uncertainties ahead.

LSE:MOH Revenue & Expenses Breakdown as at Sep 2025
LSE:MOH Revenue & Expenses Breakdown as at Sep 2025

Key Takeaways

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About AIM:ALT

Altitude Group

Provides end-to-end solutions for branded merchandise in corporate promotional products industry, print vertical markets, and the higher-education sector in North America, the United Kingdom, and Europe.

Excellent balance sheet with slight risk.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1157.5% undervalued
47 users have followed this narrative
2 users have commented on this narrative
7 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7721.4% undervalued
66 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9218.9% undervalued
22 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$19013.7% undervalued
24 users have followed this narrative
0 users have commented on this narrative
10 users have liked this narrative

Updated Narratives

WI
WisetoWealth
PYPL logo
WisetoWealth on PayPal Holdings ·

The Underrated Transformation of a Digital Payments Giant

Fair Value:US$90.3137.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BL
Blagget
TERA logo
Blagget on Terra Balcanica Resources ·

The C$4M Explorer Positioned to Become Europe's First Antimony Mine

Fair Value:CA$0.487.5% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DA
CHTR logo
david_6nroa on Charter Communications ·

Charter is undervalued - Here's why.

Fair Value:US$87.0741.6% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.919.1% undervalued
81 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28026.1% undervalued
185 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.6% undervalued
71 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0